The European Commission just confirmed that it addressed today on the basis of EU antitrust rules, requests for information to certain pharmaceutical companies asking them to submit copies of their patent settlement agreements. "The requests cover patent settlement agreements concluded between originator and generic pharmaceutical companies in the period from 1 July 2008 to 31 December 2009 and relating to the EU/EEA. The Commission is in particular looking at patent settlements where an originator company pays off a generic competitor in return for delayed market entry of a generic drug. This monitoring exercise has been launched in the light of the findings of the competition inquiry into the pharmaceutical sector Inquiry."
Read the complete Commission press release here.
Comments